The procedures of protein extraction and Western blotting were performed as previously described [26]. Specific primary antibodies used in this study included those against p53, p-p53, p21, p-Rb, PCNA, CDK2, CDK4, cyclin A, cyclin B1, cyclin D1, FAS, Caspase-8, Bax, Caspase-9, Caspase-3, MMP2, and MMP9 (Santa Cruz, CA, USA); β-actin (iReal Biotechnology Co., Ltd., Hsinchu, Taiwan). The antigen–antibody complexes were detected by a chemiluminescence imaging analyzer (GE LAS-4000, GE Healthcare Life Sciences, NJ, USA), and the signal intensity of each band was determined by using ImageJ software 1.47t (National Institutes of Health, Bethesda, MD, USA).
Do you have any questions about this protocol?
Post your question to gather feedback from the community. We will also invite the authors of this article to respond.